期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

康脉胶囊对人乳癌MCF-7细胞组织因子促凝血活性的影响研究 被引量：1

下载PDF
导出
摘要 为探讨康脉胶囊治疗和预防恶性肿瘤患者静脉血栓栓塞的机制,本研究以人乳癌细胞系MCF-7细胞为研究对象,采用一期凝血法、western blotting和流式细胞仪分别研究了康脉胶囊对MCF-7细胞组织因子促凝血活性的影响和对MCF-7细胞组织因子表达的影响。研究结果显示,康脉胶囊能明显降低MCF-7细胞组织因子促凝血活性;对MCF-7细胞组织因子表达水平具有明显的下调作用。
作者 邵青 李令根
机构地区 黑龙江中医药大学 黑龙江中医药大学附属第一医院
出处 《中医药学报》 CAS 2012年第5期101-103,共3页 Acta Chinese Medicine and Pharmacology
关键词 恶性肿瘤 静脉血栓栓塞 组织因子 MCF-7细胞 中药康脉胶囊
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Sousou T, Khorana AA. New Insights Into Cancer - Associated Thrombosis[ J]. Arterioscler Thromb Vasc Biol,2009,29:316 -320.
  • 2Sud R, Khorana AA. Cancer - associated thrombosis : risk factors, candidate biomarkers and a risk model[ J ]. Thromb Res,2009,123 ( 4 ) : 18 -21.
  • 3Heir JA. Cancer and venous thromboembolism:scope of the problem [J]. Cancer Control,2005,12( 1 ) :5 - 10.
  • 4Mackman N. The many faces of tissue factor[J]. J Thromb Haemost, 2009,7 : 136 - 139.
  • 5Schaffner F, Ruf W. Tissue factor and protease - activated receptor signaling in cancer [ J ]. Semin Thromb Hemost, 2008,34 : 147 - 153.
  • 6Ten Care H, Falanga A. Overview of the postulated mechanisms linking cancer and thrombosis [ J ]. Pathophysiol Haemost Thromb, 2008,36 : 122 - 130.
  • 7Raj S, Kasthuri, Mark B,Taubman, Mackman N. Role of Tissue Factor in Cancer[ J ], J Clin Onco1,2009 ,27 :4834 -4838,.
  • 8Frederick R, Rickles, Patierno S, Fernandez PM. Tissue Factor, Thrombin, and Cancer[ J ]. Chest ,2003,124:58 - 68.
  • 9David A,Manly, Boles J, Mackman N. Role of Tissue Factor in Venous Thrombosis[ J ]. Annu Rev Physio1,2011,73 :515 - 525.
  • 10邵青,李令根.康脉胶囊对人乳癌MCF-7细胞葡萄糖调解蛋白78表达的影响[J].中医药信息,2012,29(3):45-47. 被引量：1

二级参考文献9

  • 1李令根,李天宇,赵钢,高杰.康脉注射液联合康脉Ⅱ号胶囊治疗非急性期下肢深静脉血栓形成的临床观察[J].中国中西医结合杂志,2004,24(8):757-758. 被引量：5
  • 2Sousou T, Khorana AA. New Insights Into Cancer - Associated Throm- bosis[ J]. Arterioscler Thromb Vasc Biol,2009 ,29 :316 -320.
  • 3Sud R, Khorana AA. Cancer - associated thrombosis : risk factors, can- didate biomarkers and a risk model[ J]. Thromb Res,2009,123 Sup- pl. 4 : S18 - S21.
  • 4Mackman N. The many faces of tissue factor[J]. J Thromb Haemost, 2009,7:136 - 139.
  • 5Schaffner F, Ruf W. Tissue factor and protease - activated receptor signaling in cancer[ J]. Semin Thromb Hemost,2008,34:147 - 153.
  • 6Ten Cate H, Falanga A. Overview of the postulated mechanisms linking cancer and thrombosis[ J ]. Pathophysiol Haemost Thromb, 2008,36 : 122 - 130.
  • 7Al - Hashimi AA, Caldwell J, Gonzalez - Gronow M, et al. Binding of anti - GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores [ J ]. Journal of Biological Chemistry, 2010, 285 : 28912 - 28923.
  • 8Watson LM, Chan AK, Berry LR, et al. Overexpression of the 78 - kDa glucose - regulated protein/immunoglobulin - binding protein (GRF78/BiP) inhibits tissue factor procoagulant activity[J]. J Biol Chem,2003,278(19) :17438 - 17447.
  • 9Berger CL, Dong ZM, Hanlon D, et al. A lymphocyte cell surface heat shock protein homologous to the endoplasmic reticulum chaperone,im- munoglobulin heavy chain binding protein BIP [ J ]. Int. J. Cancer, 1997,71:1077 - 1085.

同被引文献14

引证文献1

中医药学报
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部